N/A
Completed N=425
A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects
Abdominal Wall Defects
Source: ClinicalTrials.gov NCT01214252 ↗
Enrolled (actual)
425
Serious AEs
—
Results posted
Dec 2012
Primary outcomePrimary: Confirmed Hernia Recurrence — 20 participants
Summary
To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Confirmed Hernia Recurrence |
20 | — |
| SECONDARY Total Unconfirmed Hernia or Hernia Recurrence |
9 | — |
| SECONDARY Hernia or Hernia Recurrence by Year From Year 2 to Last Year Observed |
26; 19; 5; 4; 1; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Equal or over 18 years of age
- Had undergone surgical repair or reconstruction of abdominal wall defects, ventral hernias or incisional hernias using Permacol Surgical Implant.
- At least 12 months of follow-up post date of surgery (-30 days)
- Undergone open or laparoscopic repairs
Exclusion Criteria
- Had undergone inguinal, parastomal, diaphragmatic or paraesophageal/hiatal hernia repair
- Any prior use of Permacol in abdominal wall repair
Data sourced from ClinicalTrials.gov (NCT01214252). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.